J&J cuts COVID vaccine sales forecasts, citing high supplies and lagging demand
Dive Brief:
Johnson & Johnson is lowering its forecast for COVID-19 vaccine sales, announcing Tuesday it will has suspended its guidance of $3 billion to $3.5 ...























